Airobes, LLC

Airobes is a biotechnology company that converts captured carbon dioxide into a carbon feedstock for bacterial fermentation, enabling the production of recombinant proteins. The company uses algae to metabolically convert CO2, substituting traditional, emission-intensive sugars with a more sustainable and cost-effective alternative. This technology is designed to be source-agnostic, capable of utilizing CO2 captured directly from the air or from industrial sources, thereby advancing a circular bioeconomy.

By leveraging captured CO2 as a valuable resource rather than an waste stream, Airobes provides recombinant proteins for industries including pharmaceuticals, biotechnology research, cosmetics, and agriculture. The company’s business model focuses on product value, allowing partners to retain ownership of tax incentives and credits. This approach aims to provide scalable and consistent biomanufacturing solutions while contributing to net-zero goals.